Department of Anesthesiology and Pain Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu City, Chiba 279-0021, Japan.
Mediators Inflamm. 2019 Mar 17;2019:1919538. doi: 10.1155/2019/1919538. eCollection 2019.
Macrophages are key immune system cells involved in inflammatory processes. Classically activated (M1) macrophages are characterized by strong antimicrobicidal properties, whereas alternatively activated (M2) macrophages are involved in wound healing. Severe inflammation can induce postoperative complications during the perioperative period. Invasive surgical procedures induce polarization to M1 macrophages and associated complications. As perioperative management, it is an important strategy to regulate polarization and functions of macrophages during inflammatory processes. Although propofol has been found to exhibit anti-inflammatory activities in monocytes and macrophages, it is unclear whether propofol regulates the functions of M1 and M2 macrophages during inflammatory processes. This study therefore investigated the effects of propofol on human macrophage polarization. During M1 polarization, propofol suppressed the production of IL-6 and IL-1 but did not affect TNF- production. In contrast, propofol did not affect the gene expression of M2 markers, such as IL-10, TGF-, and CD206, during M2 polarization. Propofol was similar to the GABA agonist muscimol in inducing nuclear translocation of nuclear factor-E2-related factor 2 (Nrf2) and inhibiting IL-6 and IL-1, but not TNF-, production. Knockdown of Nrf2 using siRNA significantly reduced the effect of propofol on IL-6 and IL-1 production. These results suggest that propofol prevents inflammatory responses during polarization of human M1 macrophages by suppressing the expression of IL-6 and IL-1 through the GABA receptor and the Nrf2-mediated signal transduction pathway.
巨噬细胞是参与炎症过程的关键免疫系统细胞。经典激活(M1)巨噬细胞的特征是具有强大的抗微生物特性,而替代性激活(M2)巨噬细胞则参与伤口愈合。严重的炎症会在围手术期引起术后并发症。侵袭性手术程序会诱导 M1 巨噬细胞极化和相关并发症。作为围手术期管理,调节巨噬细胞在炎症过程中的极化和功能是一项重要策略。尽管已发现异丙酚在单核细胞和巨噬细胞中具有抗炎活性,但尚不清楚异丙酚是否在炎症过程中调节 M1 和 M2 巨噬细胞的功能。因此,本研究调查了异丙酚对人巨噬细胞极化的影响。在 M1 极化期间,异丙酚抑制了 IL-6 和 IL-1 的产生,但不影响 TNF-的产生。相比之下,异丙酚在 M2 极化期间不影响 M2 标志物(如 IL-10、TGF-β和 CD206)的基因表达。异丙酚与 GABA 激动剂 muscimol 相似,可诱导核因子-E2 相关因子 2(Nrf2)的核易位,并抑制 IL-6 和 IL-1 的产生,但不抑制 TNF-的产生。使用 siRNA 敲低 Nrf2 可显著降低异丙酚对 IL-6 和 IL-1 产生的影响。这些结果表明,异丙酚通过抑制 GABA 受体和 Nrf2 介导的信号转导通路下调 IL-6 和 IL-1 的表达,从而防止人 M1 巨噬细胞极化过程中的炎症反应。